Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2021 / Articles / Dec / Let’s Shake Things Up
Business & Regulation Business Practice

Let’s Shake Things Up

As the pharmaceutical industry evolves, we need new ways to celebrate its achievements

By Maryam Mahdi 12/27/2021 1 min read

Share

As 2020 drew to a close, you may have committed to a private (or public) declaration to make the most of the year ahead. To savor the small moments. To seize new opportunities and – restrictions permitting – to do as much with your time as possible. I may have set my expectations for 2021 slightly too high, but fortunately, it’s never really too late to do things differently… 

Pharma has certainly proven this over the last two years. Though the industry is notorious for its risk-averse and hesitant approach to change, its reputation has skyrocketed because of its response to the COVID-19 pandemic. The industry was quickly able to prove that it was capable of information sharing on a grand scale and adopting new mindsets towards drug development during the most crucial moments of the global fight against the disease. A report published by market research company Ipsos MORI for the ABPI was one of many that provided evidence; their data revealed that  56 percent more of the British public have a more positive perception of the industry than in previous years – citing the sector’s role in the development and distribution of COVID-19 interventions as reasons for their changed opinion (1). 

To celebrate pharma’s new attitude to drug development, manufacturing, and regulation The Medicine Maker has decided to do things a little differently too. Though we still want you to nominate the inspirational people driving innovation in our annual Power List, you’ll also be able to celebrate the achievements of businesses at the heart of the medicine making endeavor in our newly launched Company of the Year Awards. 

Prominent figures have helped influence the industry’s trajectory over the last year, but we can’t forget how, as a collective, professionals from businesses across the globe worked to make change happen on an international scale, sacrificing time and resources to protect our healthcare interests. Our new award will help give them the recognition they deserve.

Just like the Power List, the power is in your hands. You’ll have the chance to vote for the best companies across six categories: Big Pharma, Biopharma Equipment, CDMO, API Supplier, Processing Equipment, and Biggest Talking Point.

It’s simple to get involved. Check out the links below. And then join us for the celebration of the winners in April 2022! 

Nominate for the Power List: tmm.txp.to/pl-2022 

Vote for the Company of the Year Awards: tmm.txp.to/coya-intro 

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Ipsos MORI, “Myths and Vaccines: Building pharma reputation in the face of misinformation.” (2021). Available at: https://bit.ly/3Gl16Pg.

About the Author(s)

Maryam Mahdi

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

More Articles by Maryam Mahdi

False

Advertisement

Recommended

False

Related Content

What Trump’s Latest Moves Mean for the Industry
Business Practice Standards & Regulation Trends & Forecasts Bioprocessing - Upstream & Downstream
What Trump’s Latest Moves Mean for the Industry

May 27, 2025

6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

Big Bad Pharma?
Business Practice Trends & Forecasts
Big Bad Pharma?

December 1, 2014

0 min read

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Access All Areas
Business Practice Trends & Forecasts
Access All Areas

December 1, 2014

0 min read

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

Care to ‘Patent Dance’?
Business Practice Trends & Forecasts
Care to ‘Patent Dance’?

December 1, 2014

0 min read

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.